Cystic sebaceous neoplasms in Muir-Torre syndrome

Archives of Pathology and Laboratory Medicine

Volumn 127, Issue 5, 2003, Pages 614-617

  Abbott, Jared J ^a   Hernandez Rios, Pablo ^b   Amirkhan, Robin H ^b,c   Hoang, Mai P ^b  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^b UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^c VA NORTH TEXAS HEALTH CARE SYSTEM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; CANCER ADJUVANT THERAPY; CASE REPORT; COLON ADENOCARCINOMA; DERMIS; EPITHELIUM TUMOR; HEMICOLECTOMY; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LYMPH NODE METASTASIS; MALE; MITOSIS; MUIR TORRE SYNDROME; NUCLEOLUS; SEBACEOUS GLAND; SUBCUTANEOUS TISSUE; THIGH; THORAX WALL TUMOR; TUMOR VOLUME;

ADENOCARCINOMA; ADENOMA; CARCINOMA; CECAL NEOPLASMS; COLONIC NEOPLASMS; HUMANS; MALE; MIDDLE AGED; NEOPLASMS, CYSTIC, MUCINOUS, AND SEROUS; SEBACEOUS GLAND NEOPLASMS; SKIN NEOPLASMS; SUBCUTANEOUS TISSUE; SYNDROME; THIGH; THORACIC WALL;

EID: 0038078123     PISSN: 00039985     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (14)

1. Schwartz RA, Torre DP. The Muir-Torre syndrome: a 25-year retrospect. J Am Acad Dermatol. 1995;33:90-104.
2. Rutten A, Burgdorf W, Hugel H, et al. Cystic sebaceous tumors as marker lesions for the Muir-Torre syndrome. Am J Dermatopathol. 1999;21:405-413.
3. Misago N, Narisawa Y. Sebaceous neoplasms in Muir-Torre syndrome. Am J Dermatopathol. 2000;22:155-161.
4. Schwartz RA, Goldberg DJ, Mahmood F, et al. The Muir-Torre syndrome: a disease of sebaceous and colonic neoplasms. Dermatologica. 1989;178:23-28.
5. Burgdorg WHC, Pitha J, Fahmy A. Muir-Torre syndrome: histologic spectrum of sebaceous proliferations. Am J Dermatopathol. 1986;8:202-208.
6. Mahalingam M, Byers HR. Intra-epidermal and intra-dermal sebocrine adenoma with cystic degeneration and hemorrhage. J Cutan Pathol. 2000;27:472-475.
7. Lynch HT, Lynch PM, Pester J, Fusaro RM. The cancer family syndrome: rare cutaneous phenotypic linkage of Torre's syndrome. Arch Intern Med. 1981;141: 607-611.
8. Bocker T, Diermann J, Friedl W, et al. Microsatellite instability analysis: a multicenter study for reliability and quality control. Cancer Res. 1997;57:4739-4743.
9. Kruse R, Rutten A, Lamberti C, et al. Muir-Torre phenotype has a frequency of DNA mismatch-repair-gene mutations similar to that in hereditary nonpolyposis colorectal cancer families defined by the Amsterdam criteria. Am J Hum Genet. 1998;63:63-70.
10. Entius MM, Keller JJ, Drillenburg P, Kuypers KC, Giardiello FM, Offerhaus GJA. Microsatellite instability and expression of hMLH-1 and hMSH-2 in sebaceous gland carcinomas as markers for Muir-Torre syndrome. Clin Cancer Res. 2000;6:1784-1789.
11. Kruse R, Lamberti C, Wang Y, et al. Is the mismatch repair deficient type of Muir-Torre syndrome confined to mutations in the hMSH2 gene? Hum Genet. 1996;98:747-750.
12. Kruse R, Rutten A, Hosseiny-Malayeri HR, et al. "Second hit" in sebaceous tumors from Muir-Torre patients with germline mutations in MSH2: allele loss is not the preferred mode of inactivation. J Invest Dermatol. 2001;116:463-465.
13. Quin AG, Healy E, Rehman I, Sikkink S, Rees JL. Microsatellite instability in human non-melanoma and melanoma skin cancer. J Invest Dermatol. 1995; 104:309-312.
14. Southey MC, Young MA, Whitty J, et al. Molecular pathologic analysis enhances the diagnosis and management of Muir-Torre syndrome and gives insight into its underlying molecular pathogenesis. Am J Surg Pathol. 2001;25:936-941.